PubHawk
October 2024 PMID 39178623

The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials.

Beatriz Austregésilo de Athayde De Hollanda Morais, Vitória Martins Prizão, Mariana de Moura de Souza, Beatriz Ximenes Mendes, Maria Luiza Rodrigues Defante, Otavio Cosendey Martins, Adriane Maria Rodrigues

Full text PDF Download social card

Mentions

12
Peak: 2 in Feb 2025
across 3 sources since Feb 2025

Extended reach

6,342
potential audience

Total likes

89

Video views

2,987

Mentions per month

Feb 2025 – Sep 2025

Where it's discussed

  • News8 articles
  • X / Twitter2 posts
  • YouTube2 videos

AI synopsis

What people are saying

Discussions are limited to personal motivation and promotion, exemplified by comments like 'The PCOS girlies want to lose some belly fat' and casual mentions of sharing videos, which reflect low engagement and interest levels and do not delve into the scientific aspects or implications of the research.

AgreementNeither agree nor disagree

The posts do not clearly express agreement or disagreement with the publication; one seems to make a casual comment rather than engage critically.

InterestLow interest

Interest appears low, as the comments are brief, informal, and focused on personal goals rather than scientific details.

EngagementNeutral engagement

Engagement is minimal, with posts mainly promoting a video without deep discussion about the research findings.

ImpactLow impact

The discussions seem unlikely to influence or inform broader understanding or clinical practices related to the publication.

Abstract in brief

  • The meta-analysis evaluated the effects of GLP1 receptor agonists (GLP1RAs) on women with PCOS and obesity, finding that these drugs can significantly reduce waist circumference, BMI, triglycerides, and testosterone levels, thereby improving hormonal and metabolic markers.
  • The research combined data from four randomized controlled trials with 176 women, mainly using Semaglutide and Liraglutide, and showed that GLP1RAs are effective in promoting weight loss and hormonal regulation in this group.
  • Overall, the study suggests that GLP1RAs are a promising treatment option for managing obesity and hormonal imbalances in women with PCOS, though further research is needed for long-term safety and effectiveness.]
Read the full abstract

Top posts

Most liked on X and Bluesky
Kim Somm
@Kimmisomm · X

The PCOS girlies want to lose some belly fat and I'm here to help... Check out my new video https://t.co/JcQogfD6lh

Feb 13, 2025 · 2 likes · 1 share · 1,676 followers View post →
Kim Somm
@Kimmisomm · X

RT @Kimmisomm: The PCOS girlies want to lose some belly fat and I'm here to help... Check out my new video https://t.co/JcQogfD6lh

Sep 3, 2025 · 1 share · 1,676 followers View post →

All mentions

Kim Somm
@Kimmisomm · X

RT @Kimmisomm: The PCOS girlies want to lose some belly fat and I'm here to help... Check out my new video https://t.co/JcQogfD6lh

Sep 3, 2025 · 1 share · 1,676 followers View post →
Kim Somm
@Kimmisomm · X

The PCOS girlies want to lose some belly fat and I'm here to help... Check out my new video https://t.co/JcQogfD6lh

Feb 13, 2025 · 2 likes · 1 share · 1,676 followers View post →